, , , , ,

Targeted Natural Killer Cell–Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy:A Randomized Phase II Clinical Trial

|

免责声明:本网站目的在于科普相关知识传播,非盈利性质,全部资料均来源于网络,如有侵权请联系删除